TraDigital IR partners with proactive investors to sponsor ONE2ONE Virtual Investor Forum on February 23, 2021



[ad_1]

Virtual conference will feature 3 unique biotech companies from 1:00 p.m. to 2:00 p.m. ET

New York, NY, February 22, 2021 (GLOBE NEWSWIRE) – via NewMediaWire – TraDigital IR, a leading investor relations, corporate communications and digital media firm representing growing emerging public and private companies across multiple industries, today announced its partnership with Proactive Investors to sponsor the ONE2ONE Virtual Investor Forum to be held on Tuesday, February 23, 2021. Presentations from participating companies will take place from 1:00 PM ET to 2:00 PM ET.

“Each of the three companies present at Proactive’s ONE2ONE BioTech Virtual Investor Forum has an innovative approach to its mission and provides solutions in the psychedelic drug market. With 15 minute presentations and networking between attendees and a group of high quality investors, this is a great opportunity for investors to learn about the directions and missions of these unique companies, ”said MJ Clyburn, Founder and CEO of TraDigital IR.

Interested investors can RSVP to Christine corrado participate.

The three participating life sciences companies include:

Silo Pharma: A developing biotech company focused on merging traditional therapies with psychedelic research for people with indications such as depression, PTSD, Parkinson’s disease, and other rare neurological disorders.

Lobe sciences: Lobe Sciences is a growth-driven technology company with its primary interest in transformational medicines and wellness. In particular, the company targets the psychedelic market largely through acquisitions and the development of assets, products and technologies.

Therapeutic Aion: The company is focused on creating new patent-protected therapeutic formulations using medical cannabis for the treatment of patients with many types of illnesses, including cancer, psychiatric disorders, drug addiction, viral infections, obesity and the chronic inflammation. Aion Therapeutic serves customers in Canada.

About TraDigital IR

TraDigital IR is an integrated investor relations and digital communications company providing essential strategic advisory services including: analyst, investor and stakeholder relations, targeted community development, financial market strategies, corporate communications, digital media management and marketing for private and public companies.

The Tradigital IR team has extensive experience in blockchain and cryptocurrencies, life sciences, healthcare IT, fintech among many other industries and sectors. Working with leading and emerging companies, TraDigital IR connects with thousands of individual, retail and institutional investors, as well as key stakeholders and industry influencers. We use all the latest technology to present our clients’ stories to the widest possible audience.

Contact:

Mr. J. Clyburn
Founder and CEO
TraDigital IR
Telephone: 917-327-6847
Email: [email protected]

[ad_2]
Source link